Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid

Oncology Research

Volumn 10, Issue 6, 1998, Pages 313-324

  Fontana, Joseph A ^a,h   Sun, Rong Juan ^a,g   Rishi, Arun K ^a,f   Dawson, Marcia I ^a   Ordónez, José V ^e   Zhang, Yuxiang ^d   Tschang, Sheng Hung ^a   Bhalla, Kapil ^b   Han, Zhiyong ^a   Wyche, James ^c   Poirer, Guy ^a   Saeed Sheikh, M ^a   Shroot, Braham ^a   Reichert, Uve ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SRI INTERNATIONAL   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BROWN UNIVERSITY   (United States)

^e Poly (ADP Ribose) Metabolism Group   (Canada)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g Galderma R and D   (France)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Bcl 2; Bcl xl; Retinoids

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; CYTARABINE; CYTOCHROME C; MESSENGER RNA; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; RETINOID;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL DIVISION; CELL STRAIN HL 60; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; METABOLISM; MITOCHONDRION; PHYSIOLOGY; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASE 3; CASPASES; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTARABINE; CYTOCHROME C GROUP; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOIDS; RNA, MESSENGER; UP-REGULATION;

EID: 17144451884     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Vaux, D. L.; Strasser, A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93:2239-2244; 1996
2. Ellis, R. E.; Yuan, J.; Horvitz, H. R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7:663-698; 1991.
3. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462; 1995.
4. Raff, M. Social control on cell survival and cell death. Nature 356:397-400; 1993.
5. Steller, H. Mechanisms and genes of cellular suicide. Science 267: 1445-1446; 1995.
6. White, E. Life, death and the pursuit of apoptosis. Genes Dev. 10: 1-15; 1996.
7. Martin, S. J.; Green, D. R. Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349-352; 1995.
8. Kaufmann, S. H.; Desnoyers, S.; Ottaviano, Y.; Davidson, N. E.; Poirier, G. G. Specific proteolytic cleavage of poly (ADP-Ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 53:3976-3985; 1993.
9. Blagosklonny, M. V.; Schulte, T.; Nguyen, P.; Trepel, J.; Necyers, L. M. Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-Raf-I- and represents a novel c-Raf-I signal transduction pathway. Cancer Res. 56:1851-1854; 1996.
10. Kaufmann, S. H. Induction of endonucleolytic DNA cleavage in human actute myelogenous leukemia cells by etoposide. Campothecin and other cytotoxic anticancer drugs: A cautionary note. Cancer Res. 49:5870-5878; 1989.
11. Yang, E.; Korsmeyer, S. J. Molecular thanatopsis: A discourse on the bcl-2 family and cell death. Blood 88:386-401; 1996.
12. Gajewsui, T. F.; Thompson, C. B. Apoptosis meets signal transduction. Elimination of a BAD influence. Cell 87:589-592; 1996.
13. L-bak peptide complex: Recognition between regulators of apoptosis. Science 275:983-986; 1997.
14. Oltvai, Z. N.; Milliman, C. L.; Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax that accelerates programmed cell death. Cell 74:609-619; 1993.
15. Sato, T.; Hanada, M.; Bodrug, S.; Irie, S.; Iwama, N.; Boise, L. H.; Thompson, C. B.; Golemis, E.; Fong, L.; Wang, H.-G.; Reed, J. C. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91:9238-9242; 1994.
16. Tsujimoto, Y.; Gorham, J.; Cossman, J.; Jaffee, E.; Croce, C. M. The(14:18) chromosome translocation involved in B-cell neoplasms results from mistakes in VDJ joining. Science 229:1390-1393; 1983.
17. Bakhshi, A.; Jensen, J. P.; Goldman, P.; Wright, J. J.; McBride, O. W.; Epstein, A. L.; Korsmeyer, S. J. Cloning the chromosomal breakpoint of t(14:18) human lymphomas: Clustering around JH on chromosome 14 near a transcriptional unit on 18. Cell 41:899-906; 1985.
18. Cleary, M. L.; Sklar, J. Nucleotide sequence of a t(14:18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 82:7439-7443; 1985.
19. Wang, H.-G.; Rapp, U. R.; Reed, J. C. Bcl-2 targets the protein kinase RAF-1 to mitochondria. Cell 87:629-638; 1996.
20. Decaudin, D.; Geley, S.; Hirsch, T.; Castedo, M.; Marchetti, P.;
21. L antagonize mitochondrial dysfunction proceeding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57:62-67; 1997.
22. L inhibits Ara C-induced CPP32/YAMA protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res. 56:4743-4748; 1996.
23. Boise, L. H.; Gonzales, Garcia, M.; Postema, C. E.; Ding, L.; Lindsten, T.; Tuma, L. A.; Mao, X.; Nunez, G.; Thompson, C. B. Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608; 1993.
24. Krajewski, S.; Kajewska, M.; Shabain, A.; Wang, H. G.; Irie, S.; Fung, L.; Reed, J. C. Immunohistochemical analysis of in vivo patterns of bcl-X expression. Cancer Res. 54:5501-5507; 1994.
25. L overexpression inhibits progression of molecular events leading to paclitaxel induced apoptosis of human acute myeloid leukemia HL-60 cells. Cancer Res. 57: 1109-1115; 1997.
26. L can confer multidrug resistance phenotype. Blood 86:1903-1910; 1993.
27. L is expressed in neuro blastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55: 2576-2582; 1995.
28. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11:493-504; 1995.
29. Hsu, C. A.; Rishi, A. K.; Li, X-S.; Gerald, T. M.; Dawson, M. I.; Schiffer, C.; Reichert, U.; Shroot, B.; Poirer, G. C.; Fontana, J. A. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor independent pathway. Blood 12:4410-4479; 1997.
30. L expression and its dowregulation by a novel retinoid in breast carcinoma cells. Exp. Cell Res. 232:17-24; 1997.
31. Kaufmann, S. H.; Desnoyers, S.; Ottavino, Y.; Davidson, N. E.; Poirer, G. G. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: An early marker of chermotherapy-induced apoptosis. Cancer Res. 53:3976-3985; 1993.
32. Charpentier, B.; Bernardon, J. M.; Eustache, J.; Millois, C.; Martin, B.; Michel, S.; Shroot, B. Synthesis, structure, affinity relationships and biological activities of ligand/binding to retinoic acid receptor subtypes. J. Med. Chem. 38:4993; 1993.
33. Yang, J.; Liu, X.; Bhalla, K.; Kim, C. N.; Ibrado, A. M.; Cai, J.; Peng, T.-I.; Jones, D. P.; Wang, X. Prevention of apoptosis by Bcl-2: Release of cytochrome C from mitochondria blocked. Science 275:1129-1132; 1991.
34. L overexpression inhibits taxol-induced Yama protease activity and apoptosis. Cell Growth Differ. 7:1087-1094; 1996.
35. L. Cancer Res. 56:1621-1628; 1996.
36. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem. 162:156; 1987.
37. Li, X-S.; Chen, J. C.; Sheikh, M. S.; Shao, Z. M.; Fontana, J. A. Retinoic acid inhibition of insulin-like growth factor I stimulation of C-Fos mRNA levels in a breast carcinoma cell line. Exp. Cell Res. 211:68-73; 1994.
38. Sheikh, M. S.; Li, X-S.; Chen, J. C.; Shao, Z. M.; Ordonez, J. V.; Fontana, J. A. Mechanism of regulation of WAF1/Cip1 gene expression in human breast carcinoma. Role of p53-dependent and independent signal transduction pathways. Oncogene 9:3407-3415; 1994.
39. L inhibits Ara C-induced mitochondrial loss of cytochrome C and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57:3115-3120; 1997.
40. Sheikh, M. S.; Shao, Z. M.; Chen, J. C.; Ordonez, J. V.; Fontana,
41. J. A. Retinoid modulation of C-Myc and Max gene expression in human breast carcinoma. Anticancer Res. 13:1387-1392; 1993.
42. Ross, D. D.; Jonecuis, C. C.; Ordonez, J. V.; Sisk, A. M.; Wu, R. K.; Hamburger, A. W.; Nora, R. E. Estimation of cell survival by flow cytometric quantitation of fluorescein diacetate/propidium iodide viable cell number. Cancer Res. 49:3776-3782; 1989.
43. Vermes, I.; Haonen, C.; Steffens-Nakken, H.; Reutelingsperger, C. P. M. A novel assay for apoptosis. Flow cytometric detection of phosphatidyl serine expression on early apoptotic cells using fluorescein labelled annexin VJ. Immunol. Methods 184:39-51; 1993.
44. Alnemri, E. S.; Livingston, D. J.; Nicholson, D. W.; Salvesen, G.; Thornberry, N. A.; Wong, W. W.; Yuan, J. Human ICE-CED3 protease nomenclature. Cell 87:171; 1996.
45. Howard, A. D.; Kostura, M. J.; Thornberry, N.; Ding, G. J. F.; Limjuco, G.; Weidner, J.; Salley, J. P.; Hocquist, K. A.; Chaplin, D. D.; Mumford, R. A.; Schmidt, J. A.; Tocci, M. J. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-kDa IL-1α. Immunology 147:2964-2969; 1991.
46. Martin, S. J.; Green, D. R. Protease activation during apoptosis = death by a thousand cuts? Cell 82:349-352; 1995.
47. Emoto, E.; Kisaki, H.; Manome, Y.; Kharbanda, S.; Kufe, D. Activation of protein kinasc CS in human myeloid leukemia cells treated with 1-B-D-arabino furanosyl cytosine. Blood 87:1990-1996; 1996.
48. Emoto, Y.; Manome, Y.; Meinhardt, G.; Kisaki, H.; Kharbanda, S.; Robertson, M.; Ghayur, T.; Wong, W. W.; Weichselbaum, R.; Kufe, D. Proteolytic activation of protein kinase Cδ by an ICE-like protease in apoptotic cells. EMBO J. 14:6148-6156; 1995.
49. Tewari, M.; Quan, L. T.; O'Rourke, K.; Desnoyers, S.; Zeng, Z.; Beidler, D. R.; Poirier, G. G.; Salvesen, G. S.; Dixit, V. M. Yama/ CPP32β a mammalian homolog of CED-3 is a Crm A inhibitable protease that cleaves the death substrate poly (ADP-Ribose) polymearse. Cell 81:801-809; 1993.
50. Nicholson, D. W.; Ali, A.; Thornberry, N. A.; Waillancourt, J. P. Ding, C. K.; Gallant, M.; Gareau, Y.; Griffin, P. R.; Labelle, M. Lazebnik, Y. A.; Munday, N. A.; Raju, S. M.; Smulson, M. E. Yamin, T. T.; Yu, V. L.; Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43; 1993.
51. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163; 1995.
52. Bargou, R. C.; Daniel, P. T.; Mapara, M. Y.; Bommert, K.; Wagener, C.; Kallinich, B.; Royer, H. D.; Dorken, B. Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-α expression in tumor cells. Int. J. Cancer 60:854-859; 1995.
53. Yin, C.; Knudson, C. M.; Korsmeyer, S. J.; Van Dyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637-640. 1997.
54. Kluk, R. M.; Bossy-Wetzcl, E.; Green, D. R.; Newmeyer, D. D. The release of cytochrome C from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136; 1997.
55. L can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA 94:3759-3764; 1997.
56. L, and adenovirus protein EIB 19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14:405-414; 1997.
57. Memon, S. A.; Moreno, M. B.; Petrak, D.; Zararchuk, C. M. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a Tcell lymphoma. J. Immunol. 155:4644-4652; 1993.
58. Hockenbery, D. M.; Oltvai, Z. N.; Yin, X. M.; Milliman, C. L.; Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251; 1993.
59. Baffy, G.; Miyashita, T.; Williamson, J. R.; Reed, J. C. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem. 268:6511-6519; 1993.
60. Sarabia-Fernandez, M. J.; Bischoff, J. R. Bcl-2 associates with the ras-related protein R-ras p23. Nature 366:274-275; 1993.
61. Schendel, S. L.; Xie, Z.; Montal, M. O.; Malsuyama, S.; Montal, M.; Reed, J. C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 94:5113-5118; 1997.
62. L forms an ion channel in synthetic lipid membranes. Nature 385:335-341; 1996.
63. Rosse, T.; Oliver, R.; Monney, L.; Rager, M.; Conus, S.; Fellay, I.; Jansen, B.; Borner, C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome C. Nature 391:496-499; 1998.
64. L has activity independent of cytochrome C release. J. Biol. Chem. 272:30299-30305; 1997.
65. Zhivotovsky, B.; Orrenius, S.; Brustugun, D. T.; Doskeland, S. O. Injected cytochrome C induces apoptosis. Nature 391:449-450; 1998.
66. Cheng, E. H-Y.; Kirsch, D. G.; Clem, R. J.; Ravi, R.; Kastan, M. B.; Bedi, A.; Veno, K.; Hardwick, J. M. Conversion of Bcl-2 to bax line death effector by caspases. Science 278:1966-1968; 1997.
67. Lu, X.-R; Fanjul, A.; Picard, N.; Pfahl, M.; Rungta, D.; Nared-Hood, K.; Carter, B.; Piedrafita, J.; Tang, S.; Fabbrizio, E.; Pfahl, M. Novel retinoid-mediated molecules as apoptosis inducers and effective inhibitors of human lung cancer in vivo. Nat. Med. 3: 686-690; 1997.
68. Robertson, K. A.; Emami, B.; Collins, S. J. Retinoic acid resisitant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885-1889; 1992.
69. Nagy, L.; Thomazy, V. A.; Shipley, G. L.; Fesus, L.; Lamph, W.; Heyman, R. A.; Chandraratina R. A. S.; Davies P. J. A. Activation of retinoid X receptors induces apoptosis in HL-60 cell-lines. Mol. Cell. Biol. 15:3540-3551; 1995.